rs2454290

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.3793+47C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.83 in 1,603,690 control chromosomes in the GnomAD database, including 559,398 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 45166 hom., cov: 32)
Exomes 𝑓: 0.84 ( 514232 hom. )

Consequence

HSPG2
NM_005529.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0950

Publications

15 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-21873328-G-A is Benign according to our data. Variant chr1-21873328-G-A is described in ClinVar as Benign. ClinVar VariationId is 1235752.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.951 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005529.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
NM_005529.7
MANE Select
c.3793+47C>T
intron
N/ANP_005520.4
HSPG2
NM_001291860.2
c.3796+47C>T
intron
N/ANP_001278789.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPG2
ENST00000374695.8
TSL:1 MANE Select
c.3793+47C>T
intron
N/AENSP00000363827.3
HSPG2
ENST00000427897.1
TSL:5
n.355+47C>T
intron
N/AENSP00000397573.1

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114334
AN:
152024
Hom.:
45165
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.486
Gnomad AMI
AF:
0.709
Gnomad AMR
AF:
0.850
Gnomad ASJ
AF:
0.871
Gnomad EAS
AF:
0.974
Gnomad SAS
AF:
0.734
Gnomad FIN
AF:
0.866
Gnomad MID
AF:
0.816
Gnomad NFE
AF:
0.852
Gnomad OTH
AF:
0.763
GnomAD2 exomes
AF:
0.831
AC:
208892
AN:
251424
AF XY:
0.829
show subpopulations
Gnomad AFR exome
AF:
0.485
Gnomad AMR exome
AF:
0.913
Gnomad ASJ exome
AF:
0.862
Gnomad EAS exome
AF:
0.977
Gnomad FIN exome
AF:
0.860
Gnomad NFE exome
AF:
0.849
Gnomad OTH exome
AF:
0.839
GnomAD4 exome
AF:
0.839
AC:
1217163
AN:
1451548
Hom.:
514232
Cov.:
29
AF XY:
0.836
AC XY:
604278
AN XY:
722914
show subpopulations
African (AFR)
AF:
0.471
AC:
15626
AN:
33210
American (AMR)
AF:
0.904
AC:
40439
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.864
AC:
22542
AN:
26088
East Asian (EAS)
AF:
0.977
AC:
38747
AN:
39652
South Asian (SAS)
AF:
0.729
AC:
62720
AN:
86028
European-Finnish (FIN)
AF:
0.856
AC:
45738
AN:
53408
Middle Eastern (MID)
AF:
0.784
AC:
4512
AN:
5756
European-Non Finnish (NFE)
AF:
0.850
AC:
937155
AN:
1102640
Other (OTH)
AF:
0.827
AC:
49684
AN:
60052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
10642
21284
31927
42569
53211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20856
41712
62568
83424
104280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.752
AC:
114368
AN:
152142
Hom.:
45166
Cov.:
32
AF XY:
0.756
AC XY:
56231
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.486
AC:
20128
AN:
41452
American (AMR)
AF:
0.850
AC:
12998
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.871
AC:
3025
AN:
3472
East Asian (EAS)
AF:
0.974
AC:
5048
AN:
5184
South Asian (SAS)
AF:
0.734
AC:
3541
AN:
4826
European-Finnish (FIN)
AF:
0.866
AC:
9181
AN:
10596
Middle Eastern (MID)
AF:
0.816
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
0.852
AC:
57944
AN:
67996
Other (OTH)
AF:
0.764
AC:
1616
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1266
2532
3797
5063
6329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
838
1676
2514
3352
4190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.818
Hom.:
151342
Bravo
AF:
0.744
Asia WGS
AF:
0.836
AC:
2905
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.5
DANN
Benign
0.59
PhyloP100
0.095
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2454290; hg19: chr1-22199821; API